Healthcare DIVE March 24, 2023
Elise Reuter

The agency is providing a 180-day transition period for devices that were exempted during the pandemic, and said companies that currently have an EUA should start preparing.

With the COVID-19 public health emergency set to expire on May 11, medical technology companies that brought devices to market under special pandemic rules will need to prepare transition plans soon, the Food and Drug Administration said in final guidance issued on March 24.

The agency clarified what steps medtech firms will need to take if their product had an emergency use authorization (EUA), or was marketed under a pandemic exemption.

For devices with an EUA:

Device EUAs won’t expire immediately when the public health emergency ends, the FDA said. Rather, the Health...

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: FDA, Govt Agencies, Healthcare System, Medical Devices, Public Health / COVID
Friday Q&A: Stanford Biodesign’s Makower on expediting Medicare coverage for breakthrough devices
Paxlovid becomes 1st approved COVID-19 pill
FDA Approves Celltroin’s Yuflyma as Humira Biosimilar for 8 Disease States
First Ever Topical Gene Therapy Approved For “Butterfly Disease” Children
Withdrawals Of COVID-19 Biologics Should Prompt Us To Reimagine Our Drug Pipeline

Share This Article